Found: 2
Select item for more details and to access through your institution.
Population distribution and effects on drug metabolism of a genetic variant in the 5′ promotor region of CYP3A4.
- Published in:
- Clinical Pharmacology & Therapeutics, 1999, v. 66, n. 3, p. 288, doi. 10.1016/S0009-9236(99)70037-8
- By:
- Publication type:
- Article
Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.
- Published in:
- British Journal of Clinical Pharmacology, 1997, v. 43, n. 6, p. 619, doi. 10.1046/j.1365-2125.1997.00591.x
- By:
- Publication type:
- Article